Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL Jr, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T Jr, Snyder DW, Pechous PA, Spaethe SM, Roman CR, Fleisch JH.
J Pharmacol Exp Ther. 1999 Jan;288(1):286-94.PMID: 9862783 [PubMed - indexed for MEDLINE]Related articlesFree article